Your browser doesn't support javascript.
Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.
Chowdhury, Roshni Roy; D'Addabbo, Jessica; Huang, Xianxi; Veizades, Stefan; Sasagawa, Koki; Louis, David M; Cheng, Paul; Sokol, Jan; Jensen, Annie; Tso, Alexandria; Shankar, Vishnu; Wendel, Ben Shogo; Bakerman, Isaac; Liang, Grace; Koyano, Tiffany; Fong, Robyn; Nau, Allison N; Ahmad, Herra; Gopakumar, Jayakrishnan; Wirka, Robert; Lee, Andrew S; Boyd, Jack; Woo, Y Joseph; Quertermous, Thomas; Gulati, Gunsagar Singh; Jaiswal, Siddhartha; Chien, Yueh-Hsiu; Chan, Charles Kwok Fai; Davis, Mark M; Nguyen, Patricia K.
  • Chowdhury RR; Department of Microbiology and Immunology (R.R.C., Y.-H.C., M.M.D.), Stanford University, Stanford, CA, USA.
  • D'Addabbo J; CA, Department of Medicine, Section of Genetic Medicine, University of Chicago, Chicago' IL (R.R.C.).
  • Huang X; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Veizades S; Department of Cardiology, First Affiliated Hospital of Shantou University Medical College, Guangdong, China (X.H.).
  • Sasagawa K; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Louis DM; Stanford Cardiovascular Institute (S.V., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., C.K.F.C., P.K.N.), Stanford University, Stanford, CA, USA.
  • Cheng P; Edinburgh Medical School, United Kingdom (S.V.).
  • Sokol J; Centre for Inflammation Research, University of Edinburgh, Scotland (S.V.).
  • Jensen A; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Tso A; Institute for Immunity, Transplantation and Infection (D.M.L., A.J., A.T., V.S., B.S.W., A.N.N., P.K.N., M.M.D.), Stanford University, Stanford, CA, USA.
  • Shankar V; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Wendel BS; Stanford Cardiovascular Institute (S.V., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., C.K.F.C., P.K.N.), Stanford University, Stanford, CA, USA.
  • Bakerman I; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Liang G; Stanford Cardiovascular Institute (S.V., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., C.K.F.C., P.K.N.), Stanford University, Stanford, CA, USA.
  • Koyano T; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Fong R; Stanford Cardiovascular Institute (S.V., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., C.K.F.C., P.K.N.), Stanford University, Stanford, CA, USA.
  • Nau AN; Institute for Immunity, Transplantation and Infection (D.M.L., A.J., A.T., V.S., B.S.W., A.N.N., P.K.N., M.M.D.), Stanford University, Stanford, CA, USA.
  • Ahmad H; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Gopakumar J; Stanford Cardiovascular Institute (S.V., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., C.K.F.C., P.K.N.), Stanford University, Stanford, CA, USA.
  • Wirka R; Institute for Immunity, Transplantation and Infection (D.M.L., A.J., A.T., V.S., B.S.W., A.N.N., P.K.N., M.M.D.), Stanford University, Stanford, CA, USA.
  • Lee AS; Institute for Immunity, Transplantation and Infection (D.M.L., A.J., A.T., V.S., B.S.W., A.N.N., P.K.N., M.M.D.), Stanford University, Stanford, CA, USA.
  • Boyd J; Institute for Immunity, Transplantation and Infection (D.M.L., A.J., A.T., V.S., B.S.W., A.N.N., P.K.N., M.M.D.), Stanford University, Stanford, CA, USA.
  • Woo YJ; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Quertermous T; Stanford Cardiovascular Institute (S.V., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., C.K.F.C., P.K.N.), Stanford University, Stanford, CA, USA.
  • Gulati GS; Department of Medicine, Cardiovascular Medicine (J.D., S.V., K.S., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., P.K.N.), Stanford University, Stanford, CA, USA.
  • Jaiswal S; Stanford Cardiovascular Institute (S.V., P.C., J.S., A.J., A.T., I.B., G.L., T.Q., C.K.F.C., P.K.N.), Stanford University, Stanford, CA, USA.
  • Chien YH; Department of Cardiothoracic Surgery (T.K., R.F., J.B., Y.J.W.), Stanford University, Stanford, CA, USA.
  • Chan CKF; Department of Cardiothoracic Surgery (T.K., R.F., J.B., Y.J.W.), Stanford University, Stanford, CA, USA.
  • Davis MM; Institute for Immunity, Transplantation and Infection (D.M.L., A.J., A.T., V.S., B.S.W., A.N.N., P.K.N., M.M.D.), Stanford University, Stanford, CA, USA.
  • Nguyen PK; Department of Pathology (H.A., J.G., S.J.), Stanford University, Stanford, CA, USA.
Circ Res ; 130(10): 1510-1530, 2022 05 13.
Article in English | MEDLINE | ID: covidwho-1794328
ABSTRACT

BACKGROUND:

Coronary artery disease is an incurable, life-threatening disease that was once considered primarily a disorder of lipid deposition. Coronary artery disease is now also characterized by chronic inflammation' notable for the buildup of atherosclerotic plaques containing immune cells in various states of activation and differentiation. Understanding how these immune cells contribute to disease progression may lead to the development of novel therapeutic strategies.

METHODS:

We used single-cell technology and in vitro assays to interrogate the immune microenvironment of human coronary atherosclerotic plaque at different stages of maturity.

RESULTS:

In addition to macrophages, we found a high proportion of αß T cells in the coronary plaques. Most of these T cells lack high expression of CCR7 and L-selectin, indicating that they are primarily antigen-experienced memory cells. Notably, nearly one-third of these cells express the HLA-DRA surface marker, signifying activation through their TCRs (T-cell receptors). Consistent with this, TCR repertoire analysis confirmed the presence of activated αß T cells (CD4T cells had TCRs specific for influenza, coronavirus, and other viral epitopes, which share sequence homologies to proteins found on smooth muscle cells and endothelial cells, suggesting potential autoimmune-mediated T-cell activation in the absence of active infection. To better understand the potential function of these activated plaque T cells, we then interrogated their transcriptome at the single-cell level. Of the 3 T-cell phenotypic clusters with the highest expression of the activation marker HLA-DRA, 2 clusters expressed a proinflammatory and cytolytic signature characteristic of CD8 cells, while the other expressed AREG (amphiregulin), which promotes smooth muscle cell proliferation and fibrosis, and, thus, contributes to plaque progression.

CONCLUSIONS:

Taken together, these findings demonstrate that plaque T cells are clonally expanded potentially by antigen engagement, are potentially reactive to self-epitopes, and may interact with smooth muscle cells and macrophages in the plaque microenvironment.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronary Artery Disease / T-Lymphocytes / Plaque, Atherosclerotic Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Circ Res Year: 2022 Document Type: Article Affiliation country: Circresaha.121.320090

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronary Artery Disease / T-Lymphocytes / Plaque, Atherosclerotic Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Circ Res Year: 2022 Document Type: Article Affiliation country: Circresaha.121.320090